Effects of Vasopressin on Liver Tumor Blood Flow
Author Information
Author(s): D.M. Hemingway, D. Chang, T.G. Cooke, S.A. Jenkins
Primary Institution: University Departments of Surgery, Glasgow Royal Infirmary and Royal Liverpool Hospital, UK
Hypothesis
Does vasopressin infusion affect hepatic tumor blood flow in an experimental model of liver metastases?
Conclusion
Vasopressin infusion decreases hepatic arterial flow but increases tumor blood flow, potentially enhancing the delivery of chemotherapy to liver tumors.
Supporting Evidence
- Vasopressin infusion significantly increased portal venous inflow.
- Hepatic arterial flow decreased significantly after vasopressin infusion.
- The tumor:liver blood flow ratio doubled following vasopressin infusion.
Takeaway
This study shows that giving vasopressin can help more blood reach liver tumors, which might make cancer treatments work better.
Methodology
The study used a dual reference microsphere technique to measure blood flow before and after vasopressin infusion in rats with induced liver tumors.
Participant Demographics
Rats with induced liver tumors using HSN sarcoma cells.
Statistical Information
P-Value
p<0.02
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website